In addition, although three reviews (including two systematic reviews 7, 9 and one narrative review 18 on a few papers, predominately case reports/series) over auditory and vestibular symptoms of SARS-CoV-2 were published, no meta-analysis paper is available yet. 12 Despite extensive research and several meta-analyses on olfactory, gustatory, 5, 6, 14 and visual 15– 17 manifestations of COVID-19 since the start of the pandemic, the impact of the disease on the auditory and vestibular systems has received little attention so far. Likewise, the timeline of virus development from initial symptoms to moderate or severe complications, roughly five days, is long enough for the virus to enter and damage the brainstem cranial nerves and nuclei. 12, 13 Given the suspicion of COVID-19 is mostly based on its typical symptoms, patients with early-onset sensory-neural manifestations such as hearing loss, tinnitus, and/or dizziness/vertigo may be misdiagnosed, which can cause the further spread of the virus. It is also expressed by many cells, including glial cells and neurons, and can cause neurological involvement through direct or indirect mechanisms. 11 This enzyme receptor is commonly found in lung type 2 alveoli. 10 It has been shown that the neuroinvasion driven by SARS-CoV-2 is associated with the angiotensin-converting enzyme 2 (ACE2) mechanism, as a functional receptor for the virus. SARS-CoV-2 infection can lead to a wide range of extrapulmonary, sensory, and neural complications, such as sudden onset olfactory and/or gustatory dysfunction, 5, 6 otologic symptoms, 7– 9 nonspecific symptoms, and long-term neurological complications. Typical signs and symptoms based on confirmed PCR, which generally develop 5–6 d after infection (range 1–14 d), consist of fever, dry cough, fatigue, sputum production, shortness of breath, sore throat, headache, dizziness, myalgia or arthralgia, chills, nausea or vomiting, nasal congestion, diarrhea, hemoptysis, and conjunctival congestion. 2 The disease contains nonspecific symptoms, and its presentation ranges from no symptoms to severe pneumonia and death. The polymerase chain reaction (PCR) is a diagnostic test of COVID-19, which consists of the collection of upper respiratory samples via nasopharyngeal/oropharyngeal swabs. 1, 2 SARS-CoV-2, which is a novel CoV from the same family, presents flu-like symptoms. 1, 2 On January 30, 2020, the World Health Organization (WHO) officially declared the epidemic caused by SARS-CoV-2, CoV disease 2019 (COVID-19), as a public health emergency of international concern. During the past two decades, several viral epidemics such as the severe acute respiratory syndrome coronavirus (SARS-CoV), H1N1 influenza, and the Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported.